HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
PFE
Pfizer Inc
Healthcare Drug Manufacturers - General · New York, USA · Reports in usd
Market Cap: $152.69B
Market Cap
$152.69B
Enterprise Val
$204.18B
P/E Ratio
35.25
P/B Ratio
1.79
Trailing PEG (1Y)
-0.33
As Of
Aug 13, 2026

Overview & Key Metrics

Reporting period: Jun 28, 2026 · Q2 2026
Book Value$85.49B
Gross Margin72.78%
Profit Margin72.78%
Return on Equity4.89%
Return on Assets2.10%
Current Ratio1.27
Debt/Equity0.74
LT Debt/Equity0.71
Revenue Per Share2.64

Income Statement

Jun 28, 2026
Revenue$15.03B
Cost of Revenue$4.09B
Gross Profit$10.94B
R&D$2.81B
SG&A$3.41B
Operating Expenses$11.59B
Operating Income-$652.0M
Interest Expense$0.00
Tax Expense-$407.0M
Net Income-$247.0M
EPS (Basic)$-0.04
EPS (Diluted)$-0.04
EBIT-$654.0M
EBITDA$968.0M
Consolidated Income-$237.0M
Non-Controlling Interests$10.0M

Balance Sheet

Jun 28, 2026
Cash & Equivalents$976.0M
Accounts Receivable$12.49B
Inventory$9.95B
Current Assets$41.36B
LT Investments$1.56B
Property, Plant & Equipment$19.03B
Intangibles$118.47B
Non-Current Assets$159.77B
Total Assets$201.13B
Accounts Payable$4.58B
Current Debt$2.70B
Current Liabilities$32.65B
LT Debt$60.50B
Non-Current Liabilities$82.99B
Total Liabilities$115.64B
Total Debt$63.19B
Retained Earnings$112.09B
Shareholder Equity$85.19B
Shares Outstanding5,699,444,169

Cash Flow Statement

Jun 28, 2026
Operating Cash Flow$835.0M
Investing Cash Flow$2.11B
Financing Cash Flow-$3.66B
CapEx-$533.0M
Free Cash Flow$302.0M
Depreciation & Amort.$1.62B
Stock-Based Comp$249.0M
Acquisitions / Disposals$1.88B
Investment Activity$765.0M
Debt Issued/Repaid-$1.19B
Equity Issued/Repaid$0.00
Dividends Paid-$2.45B
Net Change in Cash-$727.0M
Data cached · Meta live · Daily live · Statements live · TTL 24h